lenz: stivarga (regorafenib) treatment, dosing strategies
Published 9 years ago • 1.9K plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:20
dosing of stivarga
-
0:56
philip philip, md on stivarga (regorafenib) dosage in 2nd line treatment of mcrc
-
3:18
a dose-escalation study of regorafenib in mcrc
-
1:47
alan venook, md relays the optimal dose for regorafenib (stivarga) in the 2nd line treatment of mcrc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
3:14
when you have decided to prescribe regorafenib
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
9:34
regorafenib in colorectal cancer
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
2:14
stellar-303: xl092 with atezolizumab compared to regorafenib in patients with mcrc
-
2:58
treatment response and side effects with regorafenib
-
1:09
survival benefit confirmed in real-life analysis of second-line regorafenib in hcc
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc